Confirming the Drugs Controller General Of India (DCGI) approval, Serum Institute of India CEO Adar Poonawalla on Tuesday tweeted: '@SerumInstIndia's brand Covovax has completed bridging studies in India and has been granted Emergency Use Authorisation by DCGI for adults and for children above the age of 12. Younger age groups will follow shortly.'
Most of the pharma units are failing in documentation, and validation processes, and many don't have full-fledged quality control laboratories.
Noting that various mathematical models meant for predicting coronavirus waves have repeatedly failed to give reliable results due to a small sample size, the Centre on Tuesday said it is closely following the virus trajectory globally, given the emergence of its new variants.
The vaccine candidate -- 'Covaxin' -- is being indigenously developed by the Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR).
So far, no other vaccine has been approved globally for children below 12 years. Sohini Das reports.
A bench of justices BR Gavai and Sanjay Karol told the Centre that from reports of experts and articles, it appears that KNP does not seem to be sufficient for such large number of cheetahs and the Union government may consider shifting them to other sanctuaries.
The Subject Expert Committee on COVID-19 of the CDSCO on October 12 after deliberating Bharat Biotech's EUA application had recommended granting emergency use approval to Covaxin for use in the 12-18 years age group with certain conditions.
The much-awaited report of the Justice Hema Committee, the government-appointed panel in 2019 that studied issues faced by women in the Malayalam film industry, comprises explosive accounts of harassment, exploitation, and ill-treatment being faced by women.
Invest with a 5 to 7 year horizon so that you are able to ride out price volatility and benefit from the long-term trends of demand and macroeconomic shifts.
The Art of Living case will go down as a test for environment activism in the country, notes M Rajaque Rahman.
'Subjecting each such creative content to scrutiny will impose burdens on the OTT platforms and impact user experience.'
In a report submitted Monday to Rajya Sabha chairman and Vice President M Venkaiah Naidu, the Parliamentary Standing Committee on Home Affairs also said there was a need for a comprehensive public health law to keep a tab on private hospitals and check black-marketing of medicines.
If the DCGI grants regular marketing authorisation, Covishied will be the second vaccine in the world to receive such approval.
According to the recommendations of the Subject Expert Committee (SEC) meeting held on July 30, which have been approved by the Drugs Controller General of India (DCGI), Sputnik-Light is the same as the component-1 of Sputnik V and as its safety and immunogenicity data in the Indian population has already been generated in a trial here, there seems to be inadequate data and justification for conducting a separate, similar trial.
Many companies globally are working on plasma research to develop and manufacture hyperimmune globulin therapies from plasma donations.
The Supreme Court on Friday said it has no reason to "discredit" SEBI, which probed allegations against the Adani group, as there was no material before it to doubt what the market regulator has done and the court does not have to treat what was set out in the Hindenburg report as a "true state of affairs".
Bharat Biotech is targeting to manufacture one billion doses of its intra-nasal vaccine in 2022 which is under clinical trials now.
Bharat Biotech applied to the Drugs Controller General of India (DCGI) seeking permission for conducting phase 1 and phase 2 clinical trials of the intranasal vaccine following which the subject expert committee of the CDSCO on Tuesday deliberated on the application and recommended granting permission for phase 1 trial.
The approval by the Drugs Controller General of India comes following recommendations by the Subject Expert Committee on COVID-19 of the Central Drugs Standard Control Organisation.
Biological E has received approval for conducting phase II/III human clinical trial of COVID-19 vaccine candidate Corbevax on children above five years and adolescents, the Department of Biotechnology (DBT) said on Friday.
While Lupin is working on a Remdesivir powder for inhalation, Glenmark has tied up with a Canadian Biotech firm for nitric oxide nasal spray that reduces Sars-CoV-2 viral load and thus transmission.
The Goods and Services Tax (GST) Council, scheduled to meet on June 22, could take a call on ending uncertainty on taxing foreign airlines and shippers as regards certain services, a senior official in the know told Business Standard. He said the Council was expected to decide on exempting the services in question from GST - aircraft lease rentals, maintenance, crew salaries, etc. These services are provided by foreign airlines to their Indian operations.
What stood out in his 15-year journey as a member of the political executive at the Centre was his glowing record as India's most successful and effective finance minister. Both as prime minister and finance minister, he understood the importance of gradualism, except when the economy or the polity was in a crisis.
The Supreme Court on Thursday asked a petitioner, who has sought the constitution of an independent committee under a retired apex court judge to inquire into the incidents of sexual assault and violence in Manipur, to mention his plea for listing before a bench headed by Chief Justice D Y Chandrachud.
Paris Games quota-winning women wrestlers on Friday pleaded with the national federation not to subject them to selection trials, saying that every single step they take and every little thing they do from now on will have a bearing on India's medal chances at the Olympics.
The Pune-based vaccine major has entered into a collaboration with the University of Oxford and AstraZeneca to manufacture the vaccine.
The 19-member National Syllabus and Teaching Learning Material Committee (NSTC) will be headed by National Institute of Educational Planning and Administration (NIEPA) chancellor MC Pant and develop textbooks for classes 3 to 12.
The committee has also recommended highlighting 'Hindu victories' in various battles in the textbooks.
Hindustan Unilever (HUL)'s decision to split its beauty and personal care division and place a renewed focus on digital has been driven by its aim to serve the consumer of tomorrow, say analysts and brand experts. HUL managing director and chief executive officer Rohit Jawa is looking to make the company 'future ready', and while these bets are not for the short-term, they will eventually pay off as the Indian consumer is young and digital friendly, they add. "Rohit Jawa comes with digital experience and he is preparing to steer HUL into serving the future consumer who is more digital friendly," said Sachin Bobade, vice-president at brokerage firm Dolat Capital.
The Russian vaccine has been registered in more than 55 countries and is gaining recognition in the virtual world -- being the only to have its own Facebook page, YouTube channel and a Twitter handle, reports Aneesh Phadnis
If things go according to plan, the vaccine would be available in the market by the end of this year.
The Bihar State Examination Board Class 12 arts topper was on Saturday taken into custody by Patna Police's Special Investigation Team soon after she failed the re-test.
The central government's ambitious Project Cheetah is facing a major problem, with the animals translocated from South Africa developing a "winter cover", a thick coat of fur, in anticipation of African winter, the Supreme Court was told on Monday.
Paul noted that "three to four months from now, there will be other vaccines and the stockpile will be even bigger. "And more acceleration can be brought about in the vaccination programme," Paul added.
Stressed MSME borrowers would be eligible for restructuring of debt, if their accounts were classified standard.
The Allahabad high court on Wednesday extended the stay on a survey of the Gyanvapi mosque premises by the Archaeological Survey of India till Thursday.
Amid a debate on the basis of a monetary policy stance, one may be curious enough to know how non-food retail inflation has behaved over the years in India. Let the eager souls catch a glimpse of facts. In the past 10 years, non-food inflation came down below 4 per cent on two occasions - pre-Covid period of 2019-20 and now in the first four months of the current financial year (FY25).
The DCGI arrived at the conclusion on Wednesday based on the recommendations of an independent expert committee which has also opined that compensation should not be paid to the volunteer, they said.
The Serum Institute of India, Bharat Biotech and Pfizer have applied to the DCGI seeking emergency use authorisation for their COVID-19 vaccine candidates and are awaiting approval.
Currently, phase 2 and 3 clinical trials of the Oxford vaccine candidate is going on in the United Kingdom, phase 3 clinical trial in Brazil and phase 1 and 2 clinical trials in South Africa.
